0
Skip to Content
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Folder: Letters
Back
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
Folder: History of Harm
Back
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Patients
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Support Us
Back
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
  • Patient Stories,
• 11/29/24

22 and Disabled by Gadolinium | Catherine's MRI Gadolinium Toxicity Story

Previous

Losing a Doctor to one Brain MRI with Contrast Dye (TW)

Next

Cancer & Fibromyalgia - When you find a CAUSE but No One Listens, Crystal's MRI Contrast Agent Story

You Might Also Like

Related Embedded Video Item Thumbnail Explanation of an MRI-Contrast Material (Gadolinium)
Related Embedded Video Item Thumbnail Nurse Anesthetist Poisoned by MRI Contrast Agent during Cancer Treatment | Bridget's Full Story
Related Embedded Video Item Thumbnail Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents : Gadolinium Accumulation in
Related Embedded Video Item Thumbnail 2017 Hearing on Gadolinium Toxicity | Judy & Mike's MRI Story
Related Embedded Video Item Thumbnail MS and Fibromyalgia after Repeated Breast MRIs | Barbara's MRI Gadolinium Toxicity Story

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
 
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.